ACM
AVNS icon

Atika Capital Management’s Avanos Medical AVNS Stock Holding History

Atika Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-65,000
Closed -$2.11M – 67
2016
Q2 		$2.11M Buy
+65,000
New +$1.99M 0.91% 38

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Atika Capital Management's AVNS Position: Q3 2016 in Review

Atika Capital Management sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 65,000 shares — an estimated $2.11M sold.

Atika Capital Management first reported a position in AVNS in Q2 2016 and held it in 1 quarter. The position peaked at $2.11M in Q2 2016. 358 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

  • Atika Capital Management reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
  • Atika Capital Management sold 65,000 Avanos Medical shares in Q3 2016, an estimated $2.11M.
  • Atika Capital Management first reported a position in Avanos Medical in Q2 2016 and held it in 1 quarter.
  • Atika Capital Management's Avanos Medical position peaked at $2.11M in Q2 2016.
  • 358 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Atika Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.